![]() |
市场调查报告书
商品编码
1481379
全球心臟瓣膜市场规模、份额、成长分析、按类型、按位置、按最终用户、按治疗 - 行业预测 2024-2031Global Cardiac Valve Market Size, Share, Growth Analysis, By Types, By Position, By End User, By Treatment - Industry Forecast 2024-2031 |
2022年全球心臟瓣膜市场规模为72.0亿美元,预计将从2023年的76.7亿美元增长到2031年的126.9亿美元,在预测期内(2024-2031年)复合年增长率为6.50%。
技术进步正在彻底改变包括心臟衰竭在内的心血管疾病的治疗,从根本上改变治疗方法。随着心臟病盛行率的上升,人们明确地关注开拓先进产品来应对这一日益严峻的健康挑战。这种对创新的重视预计将在可预见的未来对心血管疾病管理产生重大影响,主要产业参与者推出可能进一步推动市场成长并增强治疗方法的新颖产品。 2023年至2030年心臟瓣膜市场的预期成长将受到多种因素的推动,特别是全球受心血管疾病影响的人口不断增加。从瓣膜疾病到冠状动脉疾病等与心臟相关的疾病激增,导致对心臟瓣膜置换术的需求增加,这是恢復最佳心臟功能并大大改善患者预后的关键干预措施。
Global Cardiac Valve Market size was valued at USD 7.20 billion in 2022 and is poised to grow from USD 7.67 billion in 2023 to USD 12.69 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031).
Technological advancements are revolutionizing the management of cardiovascular diseases, including heart failure, fundamentally altering treatment approaches. With the prevalence of cardiac conditions on the rise, there's a clear focus on pioneering advanced products to address this growing health challenge. This emphasis on innovation is expected to significantly impact cardiovascular disease management in the foreseeable future, with major industry players introducing novel products that are likely to drive market growth further and enhance treatment methodologies. The anticipated growth in the cardiac valve market from 2023 to 2030 will be propelled by various factors, notably the increasing global population affected by cardiovascular diseases. This surge in heart-related ailments, ranging from valvular disorders to coronary artery disease, has led to a heightened demand for cardiac valve replacements, crucial interventions that restore optimal cardiac function and greatly enhance patient outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Valve Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cardiac Valve Market Segmental Analysis
The global Cardiac Valve market can be categorized into the following segments. Based on Types, the market can be categorized into Mechanical Valves, Tissue/Bioprosthetic Valves, Transcatheter Heart Valves/Percutaneous Heart Valves And Others. Based on Treatment, the market can be categorized into Cardiac Wall Repair, Cardiac Wall Replacement. Based on Position, the market can be categorized into Mitral Valve, Aortic Valve And Other Position. Based on Treatment, the market can be categorized into Cardiac Valve Replacement, Cardiac Valve Repair And Other. Based on End User, the market can be categorized into Cardiac Research Institute, Hospital & Clinics, Specialty Centers And Others. Based on Region, the market can be categorized into North America, Europe, Asia Pacific, The Middle East and Africa.
Drivers of the Global Cardiac Valve Market
The burgeoning elderly population, along with the trend towards more sedentary habits, is a key factor fueling the expansion of the market. Progress in heart valve technology and greater recognition of surgical options are additional contributors to this surge, particularly due to the rising demand for minimally invasive treatments. For example, according to the American College of Cardiology, around 5 million Americans grapple with heart valve disease each year..
Restraints in the Global Cardiac Valve Market
Significant hurdles impede the advancement of the market, primarily stemming from stringent government regulations dictating the progression, production, and application of medical products, particularly cardiac valves. Adhering to these regulatory frameworks entails a complex and resource-intensive process, involving extensive testing and meticulous documentation to ensure the safety and efficacy of these vital medical devices.
Market Trends of the Global Cardiac Valve Market
The expanding Cardiac Valve devices market is driven by several key factors, notably the rising prevalence of heart valve diseases and the approval of new and improved cardiac valves by regulatory bodies. This growth is particularly propelled by the increasing incidence of conditions such as rheumatic heart disease, which affects approximately 39 million people worldwide according to the World Heart Federation's 2022 report. Rheumatic heart disease, resulting from chronic rheumatic fever affecting heart valves, underscores the urgent demand for innovative solutions in cardiac valve technology.